Michael Grissinger Aprea Therapeutics, Inc. (APRE) insider trading activity

Michael Grissinger is Director of Aprea Therapeutics, Inc.. Currently has a direct ownership of 1,844 shares of APRE, which is worth approximately $5,863. The most recent transaction as insider was on Jun 20, 2024, when has been sold 1,045 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.84K

0% 3M change

130.79% 12M change

Total Value Held $5,863

Michael Grissinger Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 20 2024	BUY Grant, award, or other acquisition	-	1,045 Added 36.17%	1,844 Common Stock
Aug 23 2023	BUY Grant, award, or other acquisition	-	500 Added 38.49%	799 Common Stock
Jul 28 2022	BUY Grant, award, or other acquisition	-	5,995 Added 50.0%	5,995 Common Stock

Also insider at

AKTX

Akari Therapeutics Plc Healthcare